Share Twitter LinkedIn Facebook Email Joanne Lager, M.D. Head of Oncology Development, Sanofi Discusses Whats Next For Isatuximab At The 60th ASH Annual Meeting on Dec 1, 2018.
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read
